Amgen Inc.

Amgen Inc., a biotech manufacturer headquartered in Thousand Oaks, delivers a broad portfolio of oncology, immunology, and cardiovascular therapeutics—including Enbrel, Repatha, and Prolia—to global healthcare providers, driving growth through strategic partnership alliances.

Headquarters: United States (USA)

Website: Visit Site 🔗
Type: Corporation

Company Profile

Sector: Manufacturing
Industry: Semiconductor Manufacturing

Employees: 28,000
HQ: Thousand Oaks

Unlock the full potential.

Get access to Relative P/E Ratio Valuation Histogram.

Upgrade

Traded Instruments

+ Add Instrument 1

Symbol	Name	Type	Exchange	Currency	ISIN	Status	Actions
AMGN	Amgen Inc. Cap: 185.6B \| P/E: 26.7	EQUITY	NMS	USD	US0311621009	Active	📈